Back to search

Article

Immunotherapeutic Potential of Mutated NPM1 for the Treatment of AML

2024-06-20

Abstract excerpt

Acute myeloid leukemia (AML) is a malignant disease of the blood and bone marrow that is characterized by uncontrolled clonal proliferation of abnormal myeloid progenitor cells. Nucleophosmin 1 (NPM1) gene mutations are the most common genetic abnormality in AML, detectable in blast cells from about one third of adults with AML. AML NPM1mut is recognized as a separate entity in the World Health Organization (WHO)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
96e3ef63-7d86-59d5-9765-d98ad06fbe06
DOI
10.20944/preprints202406.1388.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of AMLDOI 10.20944/preprints202406.1388.v1
Select a neighboring publication to make it the new centre.